| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2078099 | Cell Stem Cell | 2010 | 4 Pages |
Abstract
The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Hal E. Broxmeyer,